The Ability of Near-Infrared Spectroscopy to Identify Vulnerable Patients and Plaques: A Systematic Review and
Ronald D Bass1, Joseph Phillips2, Jorge Sanz Sánchez3
1School of Medicine, Georgetown University, 3800 Reservoir Road, NorthWest, Washington, DC 20007, USA.
Heart Failure Clinics
|November 12, 2023
Abstract
None:
Previous studies have analyzed the efficacy of near-infrared spectroscopy-derived lipid core burden index (LCBI) in quantifying and identifying high-risk plaques and patients at increased risk of future major adverse cardiac outcomes/major adverse cardiovascular and cerebrovascular events. A maxLCBI4mm of 400 or greater seems to be an effective threshold for classifying at-risk plaques. This meta-analysis provides a more precise odds ratio with a narrow standard deviation that can be used to guide future studies.
